In an interview with the New York Times, Rebecca Boxer, MD, discusses how a new clinical trial will serve a population greatly in need of targeted COVID-19 treatments.
Kaiser Permanente’s clinical trials help advance treatment for health conditions and diseases ranging from heart disease and cancer to AIDS and COVID-19.
In an effort to improve understanding and clinical practice guidelines around the novel coronavirus, Kaiser Permanente’s various research centers are quickly moving to investigate potential treatment for COVID-19.
A new Kaiser Permanente study of COVID-19 patients published today as a research letter in the Journal of the American Medical Association (JAMA) provides estimates for the percentage of test-positive patients requiring hospitalization and admission to the ICU.
Brian Lim, MD, an interventional gastroenterologist with Southern California Permanente Medical Group, combines award-winning research with a compassionate approach to care inspired by his father.
Kaiser Permanente research found diabetes occurred 3 times more often among normal-BMI Native Hawaiians and Pacific Islanders than normal-BMI whites.
Steven J. Jacobsen, MD, PhD, senior director of Research for Kaiser Permanente Southern California, was elected as president-elect of the American College of Epidemiology.
Read peer-reviewed articles in the latest edition of the Permanente Journal, including a special report containing the 40 abstracts from the annual Kaiser Permanente Los Angeles Research Week.
A risk calculator validated at Kaiser Permanente Northern California Emergency Departments may help safely avoid unnecessary CT scans in children 5 and older.
Three initiatives will seek to develop clinical-level interventions around safe weapon storage, suicide prevention, and risk prediction.